Hey buddy! Yes, I remain loyal to Orocobre, LAC and GALXF in the lithium sector. I think that these 3 juniors will do well and are in more solid ground than others. They are my 3 horses in lithium.
Orocobre’s stage 2 brine project has suffered delays due to COVID19, but it will eventually more than double current capacity. They are in a similar schedule as LAC. I am also excited about its Japan processing plant to refine material to higher carbonate and hydroxide quality, and its recent buying of Advantage Lithium provides an additional resource for many years in Argentina next to LAC/Ganfeng. Finally, the company has benefitted from the new CEO and from Toyota.
Galaxy has Mt. Catlin producing spodumene in Australia, a brine project in Argentina at pilot stage with better quality than LAC or OROCF (less impurities and better composition), and a large rock project in Canada. It has also benefitted from a change in CEO, who is more focused than the one before.
You know plenty about LAC....
I think all 3 will be winners, but I remain cautious due to the typical risks (Argentina’s situation, lithium prices, poor management decisions, etc.).
BTW I am still in hydrogen (PLUG), small pharma (CYDY, RLFTF and SGMO) and MJ (APHA, TCNNF and LHSIF). Most are doing very well, but they are risky....
Happy holidays!
AI
